Production of multiple brain-like ganglioside species is dispensable for fas-induced apoptosis of lymphoid cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Popa, Iuliana ^a,f   Therville, Nicole ^b,c   Carpentier, Stéphane ^b,c   Levade, Thierry ^b,c,d   Cuvillier, Olivier ^c,e   Portoukalian, Jacques ^a  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d CHU PURPAN   (France)

^e INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; FAS ANTIGEN; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID METABOLISM; LIPOGENESIS; LYMPHOID CELL; NIEMANN PICK DISEASE; NUCLEOTIDE SEQUENCE; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; LYMPHOCYTE; METABOLISM; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; GANGLIOSIDES; HUMANS; LYMPHOCYTES; SPHINGOMYELINS;

EID: 79956364991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019974     Document Type: Article

References (37)

1. Cremesti A, Paris F, Grassme H, Holler N, Tschopp J, et al. (2001) Ceramide enables Fas to cap and kill. J Biol Chem 276: 23954-23961.
2. Cuvillier O, Edsall L, Spiegel S, (2000) Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem 275: 15691-15700.
3. Gill BM, Nishikata H, Chan G, Delovitch TL, Ochi A, (1994) Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes. Immunol Rev 142: 113-125.
4. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, et al. (1995) Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci U S A 92: 8443-8447.
5. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, et al. (1994) Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180: 1547-1552.
6. De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, et al. (1997) Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science 277: 1652-1655.
7. Giammarioli AM, Garofalo T, Sorice M, Misasi R, Gambardella L, et al. (2001) GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein. FEBS Lett 506: 45-50.
8. Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, et al. (2000) GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. Faseb J 14: 2047-2054.
9. De Maria R, Rippo MR, Schuchman EH, Testi R, (1998) Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med 187: 897-902.
10. Chen HY, Varki A, (2002) O-acetylation of GD3: an enigmatic modification regulating apoptosis? J Exp Med 196: 1529-1533.
11. Tardy C, Codogno P, Autefage H, Levade T, Andrieu-Abadie N, (2006) Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim Biophys Acta 1765: 101-125.
12. Sabourdy F, Kedjouar B, Sorli SC, Colie S, Milhas D, et al. (2008) Functions of sphingolipid metabolism in mammals-lessons from genetic defects. Biochim Biophys Acta 1781: 145-183.
13. Smith EL, Schuchman EH, (2008) The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. Faseb J 22: 3419-3431.
14. Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J, (1998) CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem 273: 7560-7565.
15. Bezombes C, Segui B, Cuvillier O, Bruno AP, Uro-Coste E, et al. (2001) Lysosomal sphingomyelinase is not solicited for apoptosis signaling. Faseb J 15: 297-299.
16. Lin T, Genestier L, Pinkoski MJ, Castro A, Nicholas S, et al. (2000) Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J Biol Chem 275: 8657-8663.
17. Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, et al. (1999) Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. J Immunol 162: 7350-7357.
18. Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, et al. (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36: 1225-1229.
19. Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S, (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J Biol Chem 273: 2910-2916.
20. Jaffrézou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, et al. (1996) Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. Embo J 15: 2417-2424.
21. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M, (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015.
22. Graber D, Salvayre R, Levade T, (1994) Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells. J Neurochem 63: 1060-1068.
23. Bouchon B, Portoukalian J, Madec AM, Orgiazzi J, (1990) Evidence for several cell populations in human thyroid with distinct glycosphingolipid patterns. Biochim Biophys Acta 1051: 1-5.
24. Popa I, Vlad C, Bodennec J, Portoukalian J, (2002) Recovery of gangliosides from aqueous solutions on styrene-divinylbenzene copolymer columns. J Lipid Res 43: 1335-1340.
25. Jourdian GW, Dean L, Roseman S, (1971) The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem 246: 430-435.
26. Portoukalian J, Bouchon B, (1986) Hydrolysis of all gangliosides, including GM1 and GM2, on thin-layer plates by Vibrio cholerae neuraminidase. J Chromatogr 380: 386-392.
27. Bodennec J, Koul O, Aguado I, Brichon G, Zwingelstein G, et al. (2000) A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J Lipid Res 41: 1524-1531.
28. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, et al. (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86: 189-199.
29. Okada M, Itoh Mi M, Haraguchi M, Okajima T, Inoue M, et al. (2002) b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277: 1633-1636.
30. Okada Y, Radin NS, Hakomori S, (1988) Phenotypic changes in 3T3 cells associated with the change of sphingolipid synthesis by a ceramide analog, 2-decanoylamino-3-morpholino-1-phenylpropanol (compound RV538). FEBS Lett 235: 25-29.
31. Platt FM, Neises GR, Dwek RA, Butters TD, (1994) N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem 269: 8362-8365.
32. Malorni W, Giammarioli AM, Garofalo T, Sorice M, (2007) Dynamics of lipid raft components during lymphocyte apoptosis: the paradigmatic role of GD3. Apoptosis 12: 941-949.
33. Nagata Y, Yamashiro S, Yodoi J, Lloyd KO, Shiku H, et al. (1992) Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. J Biol Chem 267: 12082-12089.
34. Liu Y, Wada R, Kawai H, Sango K, Deng C, et al. (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103: 497-505.
35. Takamiya K, Yamamoto A, Furukawa K, Yamashiro S, Shin M, et al. (1996) Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A 93: 10662-10667.
36. Kawai H, Allende ML, Wada R, Kono M, Sango K, et al. (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276: 6885-6888.
37. Kisic A, Rapport MM, (1974) Determination of long-chain base in glycosphingolipids with fluorescamine. J Lipid Res 15: 179-80.